|
1) Danovich GM. Immunosuppressive medications and protocols for kidney transplantation. In: Danovich GM, editor. Handbook of Kidney Transplantation. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005: p. 72-3
|
|
|
|
|
2) 吉村了勇, 岡本雅彦, 貝原 聡. 腎移植における免疫抑制法. 今日の移植. 2005; 18: 587-94
|
|
|
|
|
3) Solez K, Axelsen RA, Benediktsson, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993; 44: 411- 22
|
|
|
|
|
4) Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999; 55: 713-23
|
|
|
|
|
|
5) Racusen LC, Colvin RB, Solez K, et al. Antibody‐mediated rejection criteria‐an addition to the Banff'97 classification of renal allograft rejection. Am J Transplant. 2003; 3: 708-14
|
|
|
|
|
|
6) Racusen LC, Halloran PF, Solez K, et al. Banff 2003 meeting report: new diagnostic insights and standard. American J Transplant. 2004; 4: 1562-6
|
|
|
|
|
|
7) Solez K, Colvin RB, Racusen LC, et al. Banff'05 meeting report: Differential diagnosis of chronicallograft injury and elimination of chronic allograft nephropathy (‘CAN'). Am J Transplant. 2007; 7: 518-26
|
|
|
|
|
|
8) Solez K, Colvin RB, Racusen LC, et al. Banff 05 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008; 8: 753-60
|
|
|
|
|
|
9) Hass M, Rahman MH, Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correlation with histologic findings. Am J Transplant. 2006; 6: 1829-40
|
|
|
|
|
|
10) Fidler ME, Gloor JM, Lager DJ, et al. Histological findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant. 2004; 4: 101-7
|
|
|
|
|
|
11) Montgomery RA, Hardy MA, Jordan SC, et al. Consensus opinion from the antibody-mediated rejection and desensitization protocols. Transplantation. 2004; 78: 181-5
|
|
|
|
|
|
12) Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation, II: morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 2002; 13: 779-87
|
|
|
|
|
|
13) Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens. 2002; 11: 609-18
|
|
|
|
|
|
14) Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol. 1999; 10: 2208-14
|
|
|
|
|
|
15) Nickeleit V, Andreoni K. The classification and treatment of antibody-mediated renal allograft injury: where do we stand？ Kidney Int. 2007; 71: 7-11
|
|
|
|
|
|
16) Nickeleit V, Zeiler M, Gudat F, et al. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol. 2002; 13: 242-51
|
|
|
|
|
|
17) Bohmig GA, Exner M, Habicht A, et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol. 2002; 13: 1091-9
|
|
|
|
|
|
18) Colvin RB, Nickeleit V. Renal transplant pathology. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall's Pathology of the Kidney. 6th ed. Philadelphia: Lippincott Williams ＆ Wilkins; 2007. p. 1353
|
|
|
|
|
|
19) Koo DDH, Robert ISD, Quiroga I, et al. C4d deposition in early renal allograft protocol biopsies. Transplantation. 2004; 70: 398-403
|
|
|
|
|
|
20) Mengel M, Bogers J, Bosmans JL, et al. Incidents of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant. 2005; 5: 1050-6
|
|
|
|
|
|
21) Ishii Y, Sawada T, Kubota K, et al. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int. 2005; 67: 321-2
|
|
|
|
|
|
22) Magil AB, Tinckam KJ. Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant. 2006; 21: 1382-8
|
|
|
|
|
|
23) Lorenz M, Regele H, Schillinger M, et al. Risk factors for capillary C4d deposition in kidney allografts: Evaluation of a large study cohort. Transplantation. 2004; 78: 447-52
|
|
|
|
|
|
24) Poduval RD, Kadambi PV, Josephson MA, et al. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 2005; 79: 228-35
|
|
|
|
|
|
25) Lerut E, Naesens M, Kuypers DR, et al. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year. Transplantation. 2007; 83: 1416-22
|
|
|
|
|
|
26) Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol. 2001; 12: 574-82
|
|
|
|
|
|
27) Regele H, Bohmig GA, Habicht A, et al. Capillarydeposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol. 2002; 13: 2371-80
|
|
|
|
|
|
28) Mroz A, Durlik M, Cieciura T, et al. Complement split product C4 as the indicator of immunological activity in chronic allograft rejection. Pol Merkuriusz Lek. 2003; 15: 363-5
|
|
|
|
|
|
29) Vongwiwatana A, Gourishanker S, Campbell PM, et al. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant. 2004; 4: 124-9
|
|
|
|
|
|
30) Sijpkens YW, Joosten SA, Wong M, et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int. 2004; 65: 2409-18
|
|
|
|
|
|
31) Herman J, Lerut E, Van Damme-Lombaerts R, et al. Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation. 2005; 79: 1435-40
|
|
|
|
|
|
32) Smavatkul C, Baba F, Oberley T, et al. C4d＋ chronic allograft nephropathy (CAN): Clinicopathological characteristics and transplant outcomes. Am J Transplant Congress 2004
|
|
|
|
|
|
33) Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant. 2006; 6: 2006-12
|
|
|
|
|
|
34) Mengel M, Chapman JR, Cosio FG, et al. Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis. Am J Transplant. 2007; 7: 512-7
|
|
|
|
|
|
35) Colvin RB. Eye of the needle. Am J Transplant. 2007; 7: 267-8
|
|
|
|
|
|
36) Karpinski J, Lajoie G, Cattran D, et al. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation. 1999; 67: 1162-7
|
|
|
|
|
|
37) Bosmans JL, Woestenburg A, Ysebaert DK, et al. Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts. Transplantation. 2000; 69: 2388-94
|
|
|
|
|
|
38) Haas M, Montgomery RA, Segev DL, et al. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant. 2007; 7: 576-85
|
|
|
|
|
|
39) Seron D, Moreso F. Protocol biopsies in renal transplantation: Prognostic value of structural monitoring. Kidney Int. 2007; 72: 690-7
|
|
|
|
|
|
40) Cosio FG, Grande JP, Wadei H, et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant. 2005; 5: 2464-72
|
|
|
|
|